Development of a novel enzyme-linked immunosorbent assay for the detection of cytokeratins 5, 8, and 18, and its implications in cervical cancer screening standardization

MLA

Alexander Luyten, et al. “Development of a Novel Enzyme-Linked Immunosorbent Assay for the Detection of Cytokeratins 5, 8, and 18, and Its Implications in Cervical Cancer Screening Standardization.” Journal of Clinical and Molecular Medicine, vol. 1, Jan. 2018. EBSCOhost, https://doi.org/10.15761/jcmm.1000109.

APA

Alexander Luyten, Oliver Boecher, Karl Ulrich Petry, Erwin Soutschek, Theodoros Agorastos, Inka Drechsler, Andreas M. Kaufmann, Steven A McNamara, Isabel Koch, Kimon Chatzistamatiou, & Jekaterina Vasiljeva. (2018). Development of a novel enzyme-linked immunosorbent assay for the detection of cytokeratins 5, 8, and 18, and its implications in cervical cancer screening standardization. Journal of Clinical and Molecular Medicine, 1. https://doi.org/10.15761/jcmm.1000109

Chicago

Alexander Luyten, Oliver Boecher, Karl Ulrich Petry, Erwin Soutschek, Theodoros Agorastos, Inka Drechsler, Andreas M. Kaufmann, et al. 2018. “Development of a Novel Enzyme-Linked Immunosorbent Assay for the Detection of Cytokeratins 5, 8, and 18, and Its Implications in Cervical Cancer Screening Standardization.” Journal of Clinical and Molecular Medicine 1 (January). doi:10.15761/jcmm.1000109.